Form 4: Jazz Pharmaceuticals Director Reports Stock Transaction
Insider Transaction (Form 4)
Mark Douglas Smith, a Director of Jazz Pharmaceuticals plc, reported multiple transactions in common stock on August 31, 2026.
Summary
- Tax/exercise-price withholding: disposed of 14 Ordinary Shares at $244.64 ($3,425) on August 31, 2026; holds 11,271 after (Direct).
- Tax/exercise-price withholding: disposed of 1,692 Ordinary Shares at $241.39 ($408,432) on August 31, 2026; holds 9,579 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Mark Douglas Smith — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Tax/exercise-price withholding | Ordinary Shares | 14 | $245 | $3.4K | 11,271 |
| 2026-08-31 | Tax/exercise-price withholding | Ordinary Shares | 1,692 | $241 | $408.4K | 9,579 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Tax/exercise-price withholding (14 shares) |
| 2026-08-31 | Tax/exercise-price withholding (1,692 shares) |
Keywords
insider transaction, Form 4, JAZZ, Jazz Pharmaceuticals plc, neutral, Mark Douglas Smith
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.